|
Status |
Public on Oct 12, 2021 |
Title |
Therapeutic landscape of targeting epigenetically reprogrammed vascular adaptome in the fibrotic liver of multiple species |
Organisms |
Homo sapiens; Sus scrofa |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Targeting pro-fibrotic epigenetic crosstalk in the liver circulatory ecosystem reduces liver fibrosis in multiple species
|
|
|
Overall design |
1 ctrl,ill(hc) and treated(hma) pig liver NPC sample
|
|
|
Contributor(s) |
Ding B |
Citation(s) |
34613814 |
|
Submission date |
Aug 04, 2021 |
Last update date |
Dec 21, 2021 |
Contact name |
Bi-Sen Ding |
E-mail(s) |
bsding@outlook.com
|
Organization name |
Weill Cornell
|
Street address |
York Avenue
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (2) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
GPL26351 |
Illumina NovaSeq 6000 (Sus scrofa) |
|
Samples (9)
|
|
Relations |
BioProject |
PRJNA752147 |
SRA |
SRP331163 |